Support for phosphoinositol 3 kinase and mTOR inhibitors as treatment for lupus using in-silico drug-repurposing analysis
Crossref DOI link: https://doi.org/10.1186/s13075-017-1263-7
Published Online: 2017-03-11
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Toro-Domínguez, Daniel
Carmona-Sáez, Pedro
Alarcón-Riquelme, Marta E.
Funding for this research was provided by:
novative Medicines Initiative Joint Undertaking (115565)
European Union’s Seventh Framework Programme
EFPIA companies